603858: Reply of the actual controller to the inquiry letter on Shandong Buchang Pharmaceuticals Co.Ltd(603858) abnormal fluctuation of stock trading Shandong Buchang Pharmaceuticals Co.Ltd(603858) : I have received the inquiry letter on Shandong Buchang Pharmaceuticals Co.Ltd(603858) abnormal fluctuation of stock trading sent by Shandong Buchang Pharmaceuticals Co.Ltd(603858) (hereinafter referred to as “the company” or ” Shandong Buchang Pharmaceuticals Co.Ltd(603858) “). After careful self-examination and verification, I hereby reply to the relevant questions of the inquiry letter as follows: I As the actual controller of the company, I do not plan major events involving the company, such as major asset restructuring, share issuance, acquisition, debt restructuring, business restructuring, asset stripping, asset injection, share repurchase, equity incentive, bankruptcy reorganization, major business cooperation, introduction of strategic investors:
© China Stock Market News